Proteins are susceptible to oxidation by reactive oxy gen species, where th
e type of damage induced is characteristic of the denaturing species. The i
nduction of protein carbonyls is a widely applied biomarker, arising from p
rimary oxidative insult. However, when applied to complex biological and pa
thological conditions it can be subject to interference from lipid, carbohy
drate and DNA oxidation products.
More recently, interest has focused on the analysis of specific protein bou
nd oxidised amino acids. Of the 22 amino acids, aromatic and sulphydryl con
taining residues have been regarded as being particularly susceptible to ox
idative modification, with L-DOPA from tyrosine, ortho-tyrosine from phenyl
alanine; sulphoxides and disulphides from methionine and cysteine respectiv
ely; and kynurenines from tryptophan. Latterly, the identification of valin
e and leucine hydroxides, reduced from hydroperoxide intermediates, has bee
n described and applied.
In order to examine the nature of oxidative damage and protective efficacy
of antioxidants the markers must be thoroughly evaluated for dosimetry in v
itro following damage by specific radical species. Antioxidant protection a
gainst formation of the biomarker should be demonstrated in vitro. Quantifi
cation of biomarkers in proteins from normal subjects should be within the
limits of detection of any analytical procedure. Further to this, the techn
iques for isolation and hydrolysis of specific proteins should demonstrate
that iii vitro oxidation is minimised. There is a need for the development
of standards for quality assurance material to standardise procedures betwe
en laboratories.
At present, antioxidant effects on protein oxidation in vivo are limited to
animal studies, where dietary antioxidants have been reported to reduce di
tyrosine formation during rat exercise training. Two studies on humans have
been reported last year. The further application of these methods to human
studies is indicated, where the quality of the determinations will be enha
nced through inter-laboratory validation.